Russia Begins Third Phase of Trials for Second Coronavirus Vaccine

In Russia, the State Scientific Center "Vector" has announced the timeline for post-registration studies of the coronavirus vaccine it developed. According to Gazeta.ru, the start of the third phase of trials will depend on the timeline for receiving the registration certificate for the "EpiVacCorona" vaccine, which is expected to be by the end of October.

This is the second coronavirus vaccine to be registered in Russia, following "Sputnik V."